QualifyHQ Logo

Vida

Cancer is a disease with millions of variations where even the most effective current treatment protocols will not work for many patients. We at AIDA believe that modern high-performance computing and machine learning combined with cutting-edge gene reading tools can fast forward personalized cancer therapy and improve treatment options for cancer patients.

Founded

2021

Revenue

$500K - $1.0M

Funding

$533K

View similar companies

Qualify this Company in

minutes

While other tools waste time, we help you qualify better-fit companies in minutes, so your pipeline stays healthy, your team stays productive, and your deals move faster.

Start free trial

Start 7-Day Free Trial